FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387473445> ?p ?o ?g. }

• W4387473445 endingPage "13" @default.
• W4387473445 startingPage "1" @default.
• W4387473445 abstract "Alzheimer's disease (AD) is among the highly prevalent neurodegenerative disorder of the aging brain and is allied with cognitive and behavioral abnormalities. Unfortunately, there is very limited drug discovery for the effective management of AD, and the clinically approved drugs have limited efficacy. Consequently, there is an immediate demand for the development of new compounds that have the ability to act as multitarget-directed ligands (MTDLs). As major pathological targets of the disease, the current study aimed to investigate lead natural bioactive compounds including apigenin, epigallocatechin-3-gallate, berberine, curcumin, genistein, luteolin, quercetin, resveratrol for their inhibitory potentials against β-amyloid cleaving enzyme-1 (BACE1) and monoamine oxidase-B (MAO-B) enzymes. The study compounds were docked against the target enzymes (MAO-B and BACE1) using MOE software and subsequent molecular dynamics simulations (MDS) studies. The molecular docking analysis revealed that these phytochemicals (MTDLs) showed good interactions with the target enzymes as compared to the reference inhibitors. Among these eight phytocompounds, the epigallocatechin-3-gallate compound was an active inhibitor against both drug targets, with the highest docking scores and good interactions with the active residues of the enzymes. Furthermore, the docking result of the active one inhibitor in complex with the target enzymes (epigallocatechin-3-gallate/BACE1, epigallocatechin-3-gallate/MAO-B, reference/BACE1 and reference/MAO-B) were further validated by MDS. According to the findings of our study, epigallocatechin-3-gallate has the potential to be a candidate for use in the treatment of neurological illnesses like AD. This compound has MTDL potential and may be exploited to create new compounds with disease-modifying features.Communicated by Ramaswamy H. Sarma." @default.
• W4387473445 created "2023-10-11" @default.
• W4387473445 creator A5006349736 @default.
• W4387473445 creator A5006413680 @default.
• W4387473445 creator A5029767755 @default.
• W4387473445 creator A5044868845 @default.
• W4387473445 creator A5046450444 @default.
• W4387473445 creator A5050480456 @default.
• W4387473445 creator A5051096772 @default.
• W4387473445 creator A5060134251 @default.
• W4387473445 creator A5066528366 @default.
• W4387473445 creator A5080494984 @default.
• W4387473445 date "2023-10-10" @default.
• W4387473445 modified "2023-10-16" @default.
• W4387473445 title "Phytochemicals-based β-amyloid cleaving enzyme-1 and MAO-B inhibitors for the treatment of Alzheimer’s disease: molecular simulations-based predictions" @default.
• W4387473445 cites W1969887156 @default.
• W4387473445 cites W1987983260 @default.
• W4387473445 cites W2054429963 @default.
• W4387473445 cites W2066051584 @default.
• W4387473445 cites W2077591905 @default.
• W4387473445 cites W2099246483 @default.
• W4387473445 cites W2105103540 @default.
• W4387473445 cites W2116642619 @default.
• W4387473445 cites W2130526419 @default.
• W4387473445 cites W2309442902 @default.
• W4387473445 cites W2332712348 @default.
• W4387473445 cites W2619752178 @default.
• W4387473445 cites W2737900099 @default.
• W4387473445 cites W2896526587 @default.
• W4387473445 cites W2913443579 @default.
• W4387473445 cites W2918727416 @default.
• W4387473445 cites W2944150075 @default.
• W4387473445 cites W2945065785 @default.
• W4387473445 cites W2949504121 @default.
• W4387473445 cites W2954046677 @default.
• W4387473445 cites W2964940927 @default.
• W4387473445 cites W2989052455 @default.
• W4387473445 cites W2990998939 @default.
• W4387473445 cites W2995352634 @default.
• W4387473445 cites W3006119534 @default.
• W4387473445 cites W3123184625 @default.
• W4387473445 cites W3127135885 @default.
• W4387473445 cites W3128772904 @default.
• W4387473445 cites W3176094035 @default.
• W4387473445 cites W3197365191 @default.
• W4387473445 cites W3217436924 @default.
• W4387473445 cites W4210411164 @default.
• W4387473445 cites W4220841730 @default.
• W4387473445 cites W4281668416 @default.
• W4387473445 cites W4300002057 @default.
• W4387473445 cites W4303621964 @default.
• W4387473445 cites W4304632685 @default.
• W4387473445 cites W4315781684 @default.
• W4387473445 cites W4380742075 @default.
• W4387473445 cites W4383961577 @default.
• W4387473445 doi "https://doi.org/10.1080/07391102.2023.2265494" @default.
• W4387473445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37815007" @default.
• W4387473445 hasPublicationYear "2023" @default.
• W4387473445 type Work @default.
• W4387473445 citedByCount "0" @default.
• W4387473445 crossrefType "journal-article" @default.
• W4387473445 hasAuthorship W4387473445A5006349736 @default.
• W4387473445 hasAuthorship W4387473445A5006413680 @default.
• W4387473445 hasAuthorship W4387473445A5029767755 @default.
• W4387473445 hasAuthorship W4387473445A5044868845 @default.
• W4387473445 hasAuthorship W4387473445A5046450444 @default.
• W4387473445 hasAuthorship W4387473445A5050480456 @default.
• W4387473445 hasAuthorship W4387473445A5051096772 @default.
• W4387473445 hasAuthorship W4387473445A5060134251 @default.
• W4387473445 hasAuthorship W4387473445A5066528366 @default.
• W4387473445 hasAuthorship W4387473445A5080494984 @default.
• W4387473445 hasConcept C159110408 @default.
• W4387473445 hasConcept C181199279 @default.
• W4387473445 hasConcept C185592680 @default.
• W4387473445 hasConcept C2776024655 @default.
• W4387473445 hasConcept C2776156579 @default.
• W4387473445 hasConcept C2776816829 @default.
• W4387473445 hasConcept C2777192995 @default.
• W4387473445 hasConcept C2778004101 @default.
• W4387473445 hasConcept C2778250585 @default.
• W4387473445 hasConcept C2779281246 @default.
• W4387473445 hasConcept C39398028 @default.
• W4387473445 hasConcept C41183919 @default.
• W4387473445 hasConcept C41685203 @default.
• W4387473445 hasConcept C55493867 @default.
• W4387473445 hasConcept C70899900 @default.
• W4387473445 hasConcept C71924100 @default.
• W4387473445 hasConcept C98274493 @default.
• W4387473445 hasConceptScore W4387473445C159110408 @default.
• W4387473445 hasConceptScore W4387473445C181199279 @default.
• W4387473445 hasConceptScore W4387473445C185592680 @default.
• W4387473445 hasConceptScore W4387473445C2776024655 @default.
• W4387473445 hasConceptScore W4387473445C2776156579 @default.
• W4387473445 hasConceptScore W4387473445C2776816829 @default.
• W4387473445 hasConceptScore W4387473445C2777192995 @default.
• W4387473445 hasConceptScore W4387473445C2778004101 @default.
• W4387473445 hasConceptScore W4387473445C2778250585 @default.
• W4387473445 hasConceptScore W4387473445C2779281246 @default.

• next